Department of Respiratory Medicine, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Kita 15, Nishi 7, Kita-ku, Sapporo, 060-8638, Japan.
Hokkaido Medical Research Institute for Respiratory Diseases, Minami 3, Nishi 2, Chuo-ku, Sapporo, 060-0063, Japan.
BMC Pulm Med. 2021 May 12;21(1):159. doi: 10.1186/s12890-021-01510-w.
Chronic obstructive pulmonary disease (COPD) is a heterogeneous disease with a complex progression of many clinical presentations, and clinically important deterioration (CID) has been proposed in the Western studies as a composite endpoint of disease progression. The aim of this study was to investigate the relationships between 1-year CID and the following long-term clinical outcomes in Japanese patients with COPD who have been reported to have different characteristics compared to the Westerners.
Among Japanese patients with COPD enrolled in the Hokkaido COPD cohort study, 259 patients who did not drop out within the first year were analyzed in this study. Two definitions of CID were used. Definition 1 comprised ≥ 100 mL decrease in forced expiratory volume in 1 s (FEV), ≥ 4-unit increase in St George's Respiratory Questionnaire (SGRQ) score from baseline, or moderate or severe exacerbation. For Definition 2, the thresholds for the FEV and SGRQ score components were doubled. The presence of CID was evaluated within the first year from enrollment, and analyzed the association of the presence of CID with following 4-year risk of exacerbations and 9-year mortality.
Patients with CID using Definition 1, but not any single CID component, during the first year had a significantly worse mortality compared with those without CID. Patients with CID using Definition 2 showed a similar trend on mortality, and had a shorter exacerbation-free survival compared with those without CID.
Adoption of CID is a beneficial and useful way for the assessment of long-term disease progression and clinical outcomes even in Japanese population with COPD. The definition of CID might be optimized according to the characteristics of COPD population and the observation period for CID.
慢性阻塞性肺疾病(COPD)是一种异质性疾病,具有多种临床表现的复杂进展,在西方研究中,临床上重要的恶化(CID)被提出作为疾病进展的复合终点。本研究旨在探讨在日本 COPD 患者中,与西方人相比,具有不同特征的患者,1 年 CID 与以下长期临床结局之间的关系。
在北海道 COPD 队列研究中纳入的日本 COPD 患者中,对在第一年未退出的 259 例患者进行了本研究分析。使用了两种 CID 的定义。定义 1 包括:用力呼气量 1 秒(FEV)下降≥100mL,从基线开始圣乔治呼吸问卷(SGRQ)评分增加≥4 分,或中度或重度加重。对于定义 2,FEV 和 SGRQ 评分组成部分的阈值加倍。在入组后 1 年内评估 CID 的存在,并分析 CID 的存在与以下 4 年加重风险和 9 年死亡率之间的关联。
在第 1 年使用定义 1 但没有任何单个 CID 成分的患者,与没有 CID 的患者相比,死亡率显著更高。在第 1 年使用定义 2 的患者死亡率也存在类似趋势,与没有 CID 的患者相比,无加重生存时间更短。
即使在日本 COPD 人群中,采用 CID 对于评估长期疾病进展和临床结局也是有益和有用的。根据 COPD 人群的特点和 CID 的观察期,CID 的定义可能需要优化。